Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases

被引:79
作者
Bodingbauer, M.
Tamandl, D.
Schmid, K.
Plank, C.
Schimai, W.
Gruenberger, T.
机构
[1] Med Univ Vienna, Div Gen Surg, Dept Surg, Vienna, Austria
[2] Med Univ Vienna, Inst Clin Pathol, Vienna, Austria
[3] Med Univ Vienna, Dept Radiodiag, Vienna, Austria
关键词
D O I
10.1002/bjs.5762
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: The aim of this study was to examine the relationship between surgical margin status and site of recurrence after potentially curative liver resection for colorectal metastases using an ultrasonic dissection technique. Methods: Between January 2000 and December 2003, 176 patients underwent liver resection with curative intent for colorectal metastases at a single institution. Demographics, operative data, pathological margin status, site of recurrence and long-term survival data were collected prospectively and analysed. Results: On pathological analysis, resection margins were positive in 43 patients, negative by 1-9 mm in 110, and clear by more than 9 mm in 23 patients. At a median follow-up of 33 months, 133 of 176 patients had developed a recurrence, only five of whom had recurrence at the surgical margin. Recurrence at the surgical margin was not significantly related to the size of the margin. Overall, the median time to recurrence was 12.6 months, which was independent of surgical margin size, although there was a significantly higher proportion of patients with multiple metastases in the group with a positive margin (P = 0.008). Margin status did not correlate significantly with either recurrence-free or overall survival. Conclusion: The rate of recurrence at the surgical margin was low and a positive margin was not associated with an increased risk of recurrence either at the surgical margin or elsewhere.
引用
收藏
页码:1133 / 1138
页数:6
相关论文
共 23 条
[1]  
Abdalla EK, 2004, ANN SURG, V239, P818, DOI 10.1097/01.sla.0000128305.90650.71
[2]  
Adam R, 2001, ANN SURG ONCOL, V8, P347
[3]   PATTERNS OF FAILURE FOLLOWING SURGICAL RESECTION OF COLORECTAL-CANCER LIVER METASTASES - RATIONALE FOR A MULTIMODAL APPROACH [J].
BOZZETTI, F ;
BIGNAMI, P ;
MORABITO, A ;
DOCI, R ;
GENNARI, L .
ANNALS OF SURGERY, 1987, 205 (03) :264-270
[4]   Surgical margin in hepatic resection for colorectal metastasis - A critical and improvable determinant of outcome [J].
Cady, B ;
Jenkins, RL ;
Steele, GD ;
Lewis, WD ;
Stone, MD ;
McDermott, WV ;
Jessup, JM ;
Bothe, A ;
Lalor, P ;
Lovett, EJ ;
Lavin, P ;
Linehan, DC .
ANNALS OF SURGERY, 1998, 227 (04) :566-571
[5]   Trends in long-term survival following liver resection for hepatic colorectal metastases [J].
Choti, MA ;
Sitzmann, JV ;
Tiburi, MF ;
Sumetchotimetha, W ;
Rangsin, R ;
Schulick, RD ;
Lillemoe, KD ;
Yeo, CJ ;
Cameron, JL .
ANNALS OF SURGERY, 2002, 235 (06) :759-765
[6]   100 PATIENTS WITH HEPATIC METASTASES FROM COLORECTAL-CANCER TREATED BY RESECTION - ANALYSIS OF PROGNOSTIC DETERMINANTS [J].
DOCI, R ;
GENNARI, L ;
BIGNAMI, P ;
MONTALTO, F ;
MORABITO, A ;
BOZZETTI, F .
BRITISH JOURNAL OF SURGERY, 1991, 78 (07) :797-801
[7]   DETERMINANTS OF SURVIVAL IN LIVER RESECTION FOR COLORECTAL SECONDARIES [J].
EKBERG, H ;
TRANBERG, KG ;
ANDERSSON, R ;
LUNDSTEDT, C ;
HAGERSTRAND, I ;
RANSTAM, J ;
BENGMARK, S .
BRITISH JOURNAL OF SURGERY, 1986, 73 (09) :727-731
[8]  
Elias D, 1998, J SURG ONCOL, V69, P88, DOI 10.1002/(SICI)1096-9098(199810)69:2<88::AID-JSO8>3.0.CO
[9]  
2-X
[10]   Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma [J].
Folprecht, G ;
Lutz, MP ;
Schöffski, P ;
Seufferlein, T ;
Nolting, A ;
Pollert, P ;
Köhne, CH .
ANNALS OF ONCOLOGY, 2006, 17 (03) :450-456